Review
doi: 10.5582/ddt.2020.03008.
Epub 2020 Apr 25.
Treatment of SARS-CoV-2: How far have we reached?
Affiliations
- PMID: 32336723
- DOI: 10.5582/ddt.2020.03008
Item in Clipboard
Review
Treatment of SARS-CoV-2: How far have we reached?
Drug Discov Ther.
.
Free article
Abstract
The virus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries and territories worldwide. It has been declared as pandemic by World Health Organization (WHO) and the whole world is suffering from corona virus disease 2019 (COVID-19). Currently, no treatment for SARS-CoV-2 are approved because of lack of evidence, but a number of clinical trials are in process and we are expecting fruitful results very soon. This review focuses on various approaches of treatment and few of the most recent clinical trials carried out in this field.
Keywords: SARS-CoV-2; antiviral; clinical trial; corona virus; pandemic.
Similar articles
-
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.J Infect Public Health. 2020 Oct;13(10):1405-1414. doi: 10.1016/j.jiph.2020.07.004. Epub 2020 Jul 13. J Infect Public Health. 2020. PMID: 32684351 Free PMC article.
-
Psychopharmacology of COVID-19.Psychosomatics. 2020 Sep-Oct;61(5):411-427. doi: 10.1016/j.psym.2020.05.006. Epub 2020 May 18. Psychosomatics. 2020. PMID: 32425246 Free PMC article. Review.
-
Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials.Eur Urol Focus. 2020 Sep 15;6(5):1028-1031. doi: 10.1016/j.euf.2020.05.019. Epub 2020 Jun 5. Eur Urol Focus. 2020. PMID: 32563675 Free PMC article. Review. No abstract available.
-
Potential strategies for combating COVID-19.Arch Virol. 2020 Nov;165(11):2419-2438. doi: 10.1007/s00705-020-04768-3. Epub 2020 Aug 10. Arch Virol. 2020. PMID: 32778950 Free PMC article. Review.
-
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.Antimicrob Agents Chemother. 2020 Apr 21;64(5):e00399-20. doi: 10.1128/AAC.00399-20. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32152082 Free PMC article. Review.
Cited by
-
Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic.Int J Biol Sci. 2022 Feb 14;18(5):1865-1877. doi: 10.7150/ijbs.66369. eCollection 2022. Int J Biol Sci. 2022. PMID: 35342348 Free PMC article. Review.
-
The Adverse Reactions of Lianhua Qingwen Capsule/Granule Compared With Conventional Drug in Clinical Application: A Meta-Analysis.Front Pharmacol. 2022 Jan 27;13:764774. doi: 10.3389/fphar.2022.764774. eCollection 2022. Front Pharmacol. 2022. PMID: 35153773 Free PMC article. Review.
-
Hypothesis: What is the Best We Can Do with Hydroxychloroquine for COVID-19?Clin Epidemiol. 2020 Oct 20;12:1139-1144. doi: 10.2147/CLEP.S277889. eCollection 2020. Clin Epidemiol. 2020. PMID: 33116907 Free PMC article.
-
COVID-19 and Dentistry in 72 Questions: An Overview of the Literature.J Clin Med. 2021 Feb 16;10(4):779. doi: 10.3390/jcm10040779. J Clin Med. 2021. PMID: 33669185 Free PMC article. Review.
-
Efficacy and safety of Lianhua Qingwen combined with conventional antiviral Western Medicine in the treatment of coronavirus disease (covid-19) in 2019: Protocol for a systematic review and meta-analysis.Medicine (Baltimore). 2020 Jul 24;99(30):e21404. doi: 10.1097/MD.0000000000021404. Medicine (Baltimore). 2020. PMID: 32791754 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
